Agilon Health (AGL) financials

NYSE · Health Care

$84.90 -1.21% Close Oct 30, 2026 Live

Agilon Health revenue and earnings by year

Agilon Health's revenue was $5.93 billion in the fiscal year to December 31, 2025, down 2.1% from the year before. Net income was -$391 million, -6.6% of revenue. Since the fiscal year to December 31, 2018, revenue has grown 43.4% a year on average.

RevenueNet income
$0$2.00B$4.00B$6.00B
20182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 8 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue5.936.064.322.391.521.220.790.47
Revenue growth-2.1%40.4%80.7%57.0%24.9%53.4%67.3%—
Gross profit-0.160.000.070.110.070.090.030.03
Gross margin-2.7%0.1%1.6%4.7%4.3%7.7%3.6%5.9%
Operating income-0.46-0.29-0.23-0.11-0.37-0.06-0.11-0.07
Operating margin-7.8%-4.8%-5.4%-4.4%-24.5%-4.7%-13.4%-15.2%
Net income-0.39-0.26-0.26-0.11-0.41-0.06-0.28-0.15
Net margin-6.6%-4.3%-6.1%-4.5%-26.7%-4.9%-35.6%-30.9%
Diluted EPS-$23.63-$15.83-$16.05-$6.53-$27.25———
Free cash flow-0.12-0.07-0.17-0.15-0.15-0.05-0.11-0.07

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open AGL in Markets.

How Agilon Health makes money

Revenue by segment in the quarter to June 30, 2026, as the company reports it.

SegmentRevenueShare
Medical Services$1.49B99.9%
Other Operating$1.82M0.1%

See also: AGL returns

No forecast, no recommendation. This page describes Agilon Health from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.